Who owns OLEMA PHARMACEUTICALS INC?
- Ticker: OLMA
- CUSIP Number: 68062p106
Tip: Access positions for across all investors
Analyze quarterly positions in Olema Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Olema Pharmaceuticals stock
Who bought or sold OLEMA PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BVF | 9.1M | $128M | 0% | Dec 2023 |
|
| Paradigm Biocapital Advisors | 7.9M | $111M | 1% | Dec 2023 |
|
| Logos Global Management | 4.4M | $54M | 17% | Dec 2023 |
|
| Vanguard Group | 2.7M | $38M | 58% | Dec 2023 |
|
| Cormorant Asset Management | 2.5M | $35M | -45% | Dec 2023 |
|
| Vivo Capital | 1.9M | $26M | 0% | Dec 2023 |
|
| Dimensional Fund Advisors | 1.7M | $24M | 1% | Dec 2023 |
|
| Henderson Group | 700k | $9.8M | 100% | Dec 2023 |
|
| First Light Asset Management | 631k | $8.9M | 100% | Dec 2023 |
|
| Victory Capital Management | 622k | $8.7M | 880% | Dec 2023 |
|
| Kingdon Capital Management | 550k | $7.7M | 78% | Dec 2023 |
|
| Perceptive Advisors | 540k | $7.6M | 100% | Dec 2023 |
|
| Citadel Advisors | 341k | $4.8M | -27% | Dec 2023 |
|
| Goldman Sachs Group | 316k | $4.4M | 236% | Dec 2023 |
|
| Marshall Wace | 291k | $4.1M | 235% | Dec 2023 |
|
| Deutsche Bank Aktiengesellschaft | 249k | $3.5M | 1613% | Dec 2023 |
|
| Candriam Luxembourg S.C.A. | 215k | $3.0M | 100% | Dec 2023 |
|
| Two Sigma Advisers | 181k | $2.5M | -25% | Dec 2023 |
|
| Two Sigma Investments | 166k | $2.3M | 26% | Dec 2023 |
|
| Newtyn Management | 150k | $2.1M | 0% | Dec 2023 |
|
| Jacobs Levy Equity Management | 150k | $2.1M | -39% | Dec 2023 |
|
| Bank of New York Mellon | 101k | $1.4M | 10% | Dec 2023 |
|
| Wellington Management Company | 99k | $1.4M | 0% | Dec 2023 |
|
| Charles Schwab Investment Management | 89k | $1.3M | 12% | Dec 2023 |
|
| Millennium Management | 87k | $1.2M | -59% | Dec 2023 |
|
| VR Adviser | 77k | $1.1M | 0% | Dec 2023 |
|
| Swiss National Bank | 65k | $906k | 100% | Dec 2023 |
|
| Hudson Bay Capital Management | 63k | $877k | 100% | Dec 2023 |
|
| UBS Group | 53k | $737k | 275% | Dec 2023 |
|
| J. Goldman & Co | 51k | $712k | 62% | Dec 2023 |
|
| EP Wealth Advisors | 46k | $649k | 0% | Dec 2023 |
|
| Squarepoint Ops | 46k | $642k | 100% | Dec 2023 |
|
| GSA Capital Partners | 44k | $621k | -26% | Dec 2023 |
|
| Credit Suisse | 44k | $612k | 100% | Dec 2023 |
|
| Barclays | 43k | $609k | 832% | Dec 2023 |
|
| Rhumbline Advisers | 40k | $564k | 6% | Dec 2023 |
|
| Bank of America Corporation | 40k | $563k | 6% | Dec 2023 |
|
| Fred Alger Management | 40k | $555k | 100% | Dec 2023 |
|
| ALPS Advisors | 38k | $535k | 100% | Dec 2023 |
|
| Jane Street | 36k | $507k | 100% | Dec 2023 |
|
| Jpmorgan Chase & Co | 29k | $401k | 56% | Dec 2023 |
|
| Walleye Trading Advisors | 29k | $401k | -83% | Dec 2023 |
|
| Caption Management | 27k | $379k | 100% | Dec 2023 |
|
| State of Wisconsin Investment Board | 27k | $378k | 100% | Dec 2023 |
|
| T. Rowe Price Associates | 25k | $348k | -36% | Dec 2023 |
|
| Legal & General Group | 25k | $344k | 911% | Dec 2023 |
|
| Ubs Global Asset Management Americas | 21k | $300k | 100% | Dec 2023 |
|
| Jump Financial | 20k | $278k | 100% | Dec 2023 |
|
| Simplex Trading | 19k | $261k | 100% | Dec 2023 |
|
| Mirae Asset Global Investments | 16k | $224k | 9% | Dec 2023 |
|
| SG Americas Securities | 16k | $223k | 38% | Dec 2023 |
|
| Alliancebernstein | 16k | $223k | 46% | Dec 2023 |
|
| MetLife Investment Advisors | 15k | $209k | 0% | Dec 2023 |
|
| American International | 13k | $187k | 0% | Dec 2023 |
|
| Franklin Resources | 13k | $181k | 0% | Dec 2023 |
|
| D. E. Shaw & Co | 12k | $167k | 100% | Dec 2023 |
|
| Walleye Trading | 12k | $161k | -50% | Dec 2023 |
|
| AQR Capital Management | 11k | $151k | 7% | Dec 2023 |
|
| Zurcher Kantonalbank | 9.3k | $130k | 100% | Dec 2023 |
|
| Wells Fargo & Company | 8.5k | $119k | 26% | Dec 2023 |
|
| Royal Bank of Canada | 8.1k | $113k | 81% | Dec 2023 |
|
| Virtus ETF Advisers | 7.5k | $105k | 100% | Dec 2023 |
|
| New York State Common Retirement Fund | 6.5k | $91k | -1% | Dec 2023 |
|
| China Universal Asset Management | 6.3k | $89k | 100% | Dec 2023 |
|
| Citigroup | 4.8k | $67k | 31947% | Dec 2023 |
|
| Amalgamated Bank | 2.3k | $33k | -10% | Dec 2023 |
|
| Summit Investment Advisors | 2.2k | $31k | 0% | Dec 2023 |
|
| Metropolitan Life Insurance Company | 1.5k | $22k | 0% | Dec 2023 |
|
| CWM | 1.0k | $12k | 0% | Mar 2024 |
|
| Wolff Wiese Magana | 600.00 | $6.8k | 100% | Mar 2024 |
|
| Fortitude Family Office | 319.00 | $3.6k | 0% | Mar 2024 |
|
| Daiwa Securities Group | 224.00 | $3.0k | 100% | Dec 2023 |
|
| Lindbrook Capital | 158.00 | $2.2k | 0% | Dec 2023 |
|
| Us Bancorp | 143.00 | $2.0k | 100% | Dec 2023 |
|
| NISA Investment Advisors | 40.00 | $561.000000 | 100% | Dec 2023 |
|
| GAMMA Investing | 14.00 | $157.999800 | 100% | Mar 2024 |
|
Who sold out of Olema Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Kynam Capital Management | Sep 2023 | 235k | $2.9M |
| Vontobel Holding | Sep 2023 | 164k | $2.0M |
| Aquilo Capital Management | Sep 2023 | 89k | $1.1M |
| Schonfeld Strategic Advisors | Sep 2023 | 72k | $894k |
| Endurant Capital Management | Sep 2023 | 59k | $723k |
| Algert Coldiron Investors | Sep 2023 | 48k | $588k |
| Raymond James & Associates | Sep 2023 | 30k | $371k |
| Caxton Associates | Sep 2023 | 14k | $166k |
| Raymond James Financial Services Advisors | Sep 2023 | 13k | $164k |
| Trexquant Investment | Sep 2023 | 11k | $138k |
| Ohio Pers | Sep 2023 | 2.9k | $35k |
| Federated Investors | Sep 2023 | 1.0k | $13k |